These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29119633)

  • 1. Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndrome.
    Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; de Wit MY; Unger WWJ; Berger C; van Rossum AMC; Jacobs BC
    J Peripher Nerv Syst; 2018 Mar; 23(1):67-69. PubMed ID: 29119633
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.
    Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Drenthen J; Unger WWJ; Jacobs E; van Rossum AMC; Jacobs BC
    J Neuroimmunol; 2018 Jan; 314():13-16. PubMed ID: 29301655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-GQ1b antibody as a factor predictive of mechanical ventilation in Guillain-Barré syndrome.
    Haifeng L
    Neurology; 2004 Nov; 63(10):1985; author reply 1985. PubMed ID: 15557541
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.
    Ang CW; Tio-Gillen AP; Groen J; Herbrink P; Jacobs BC; Van Koningsveld R; Osterhaus AD; Van der Meché FG; van Doorn PA
    J Neuroimmunol; 2002 Sep; 130(1-2):179-83. PubMed ID: 12225900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study.
    Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Roodbol J; Hoogenboezem T; Jacobs E; van Rijn M; van der Eijk AA; Vink C; de Wit MC; van Rossum AM; Jacobs BC
    Ann Neurol; 2016 Oct; 80(4):566-80. PubMed ID: 27490360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A family with Campylobacter enteritis: anti-GD1a antibody with/without Guillain-Barré syndrome.
    Hirano M; Kusunoki S; Asai H; Tonomura Y; Morita D; Ueno S
    Neurology; 2003 May; 60(10):1719-20. PubMed ID: 12771281
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guillain-Barré syndrome and Mycoplasma pneumoniae infection].
    Vinzio S; Andres E; Goichot B; Schlienger JL
    Ann Med Interne (Paris); 2000 Jun; 151(4):309-10. PubMed ID: 10922961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody responses in the Guillain-Barré syndrome.
    Hartung HP; Kieseier RC
    J Neurol Sci; 1999 Oct; 168(2):75-7. PubMed ID: 10526186
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.
    Arakawa H; Yuhara Y; Todokoro M; Kato M; Mochizuki H; Tokuyama K; Kunimoto F; Morikawa A
    Brain Dev; 2005 Sep; 27(6):431-3. PubMed ID: 16122631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent GBS with GD1a anti-ganglioside antibodies.
    Yalinay Dikmen P; Emre Oge A
    J Peripher Nerv Syst; 2012 Mar; 17(1):135-7. PubMed ID: 22462676
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycolipid antigens and autoantibodies in autoimmune neuropathies.
    Willison HJ; Goodyear CS
    Trends Immunol; 2013 Sep; 34(9):453-9. PubMed ID: 23770405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Guillain-Barré Syndrome and its association with infectious factors].
    Grygorczuk S; Zajkowska J; Kondrusik M; Pancewicz S; Hermanowska-Szpakowicz T
    Neurol Neurochir Pol; 2005; 39(3):230-6. PubMed ID: 15981163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 3-year-old boy with Guillain-Barré syndrome and encephalitis associated with Mycoplasma pneumoniae infection.
    Hanzawa F; Fuchigami T; Ishii W; Nakajima S; Kawamura Y; Endo A; Arakawa C; Kohira R; Fujita Y; Takahashi S
    J Infect Chemother; 2014 Feb; 20(2):134-8. PubMed ID: 24462436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACTH and cortisone in Guillain-Barré syndrome: review of the literature and report of a treated case following primary atypical pneumonia.
    BERLACHER FJ; ABINGTON RB
    Ann Intern Med; 1958 May; 48(5):1106-18. PubMed ID: 13534228
    [No Abstract]   [Full Text] [Related]  

  • 15. Nodal proteins are target antigens in Guillain-Barré syndrome.
    Devaux JJ; Odaka M; Yuki N
    J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ganglioside antibodies profile in Guillain-Barré syndrome: Correlation with clinical features, electrophysiological pattern, and outcome.
    Naik GS; Meena AK; Reddy BAK; Mridula RK; Jabeen SA; Borgohain R
    Neurol India; 2017; 65(5):1001-1005. PubMed ID: 28879885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in Guillain-Barré syndrome.
    Hartung HP; Kieseier BC; Kiefer R
    Curr Opin Neurol; 2001 Oct; 14(5):597-604. PubMed ID: 11562571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
    Samukawa M; Hamada Y; Kuwahara M; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S;
    J Neurol Sci; 2014 Feb; 337(1-2):55-60. PubMed ID: 24289889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral nerve proteins as potential autoantigens in acute and chronic inflammatory demyelinating polyneuropathies.
    Lim JP; Devaux J; Yuki N
    Autoimmun Rev; 2014 Oct; 13(10):1070-8. PubMed ID: 25172243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycranial neuropathy and sensory ataxia with IgG anti-GD1a antibody as a variant of Guillain-Barré syndrome.
    Kim SY; Kim JK; Suh CK
    J Clin Neurosci; 2013 Mar; 20(3):473-5. PubMed ID: 23164827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.